The Weekly Roundup
National Diabetes Month is an ideal time to promote awareness and survey what’s on the horizon in treatment. California scientists are pinning their hopes for a significant advance in type 1 diabetes on a new technology: a way to transplant insulin-producing cells and prevent them from being rejected. Side effects—an obstacle for type 2 diabetes patients using GLP-1 agonists—can potentially be overcome through a beta-cell pathway discovered by researchers at the University of Alabama. Also, an old asthma drug is being explored by UC San Diego and University of Michigan researchers to inhibit the enzymes IKKε and TBK1, which make it difficult for mice in their study to expend energy. Meanwhile, pharmacists are on the front line of treatment using today’s management methods, including aiding adherence and developing counseling strategies that can aid in prevention, especially among groups at high risk. It’s certainly in pharmacists’ best interest to do so.
Here are a few other stories that might be of interest:
- Get there first. A study of social media’s role in overcoming disinformation about vaccination: hit up expectant parents.
- Check out this slideshow showcasing antibiotics for resistant infections in the pipeline. (log in required)
- Feeding the beast. More speculation on Amazon and the pharmacy landscape.
- Keeping pharma “evergreen.” Extending the life of pharmaceutical patents. (log in required)
- Not so fast. FDA renews warnings against the fraudulent advertising of unproven cancer treatment claims.
- Study finds expanded use of electronic health records remains advantageous.
- “Force thyself.” Check out these strategies for managing your time amid multiple priorities.
[Editor’s note:] Our inboxes are stuffed with newsletters and our coffee tables stacked with magazines and industry digests. I’m sure yours are, too. So we’ve decided to run a weekly sampling of interesting stories, issues coverage, and business ideas we come across each week. We hope you’ll share some of your favorites, too. Drop us a line at firstname.lastname@example.org.
Sign up now to receive the latest independent
pharmacy news, tips, and resources.
Whose responsibility is it when a patient is readmitted to the hospital after a cardiac event because they couldn’t get their blood pressure under control? Or when a patient taking hydrocodone and (unknown to the physician or pharmacist) is also taking cimetidine for heartburn, ca...
While topics at the NCPA 2017 annual conference ranged broadly, one of the most talked-about themes inside and outside the halls of learning was definitely (and unsurprisingly) DIR fees. (If you missed the event, this will give you a taste that might sway you to attend...